MEIS2 and pancreatic neuroendocrine neoplasm: On the other hand, global gene expression analysis of nonmetastatic pancreatic endocrine neoplasms and metastatic pancreatic endocrine neoplasms revealed that Meis2 was downregulated in metastatic pancreatic endocrine neoplasms (Hansel et al., 2004).